Erasca
ERAS
55 hedge funds and large institutions have $920M invested in Erasca in 2021 Q3 according to their latest regulatory filings, with 55 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
36.46% more ownership
Funds ownership: 0% → 36.46% (+36%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
+$217M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
+$164M |
| 3 |
PHS
PFM Health Sciences
San Francisco,
California
|
+$107M |
| 4 |
HA
HHLR Advisors
Grand Cayman,
Cayman Islands
|
+$97.4M |
| 5 |
AG
Artal Group
Luxembourg
|
+$65.4M |
Top Sellers
ERAS Hedge Fund Activity: Q3 2021 in Review
55 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in Erasca (ERAS) for Q3 2021, worth a combined $920M.
Buyers outnumbered sellers: 55 funds opened new ERAS positions and 0 closed out — a net gain of 55 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Cormorant Asset Management, opening a new position worth an estimated $217M.
- 55 institutional investors held Erasca (ERAS) as of Q3 2021, up from 0 in Q2 2021.
- Funds reported $920M of Erasca stock for Q3 2021.
- 55 funds opened new Erasca positions in Q3 2021 and 0 closed out, a net change of +55 holders.
- The largest Erasca buyer in Q3 2021 was Cormorant Asset Management, an estimated $217M added.
Based on aggregated 13F filings for Q3 2021.